LOGO
LOGO

Corporate News

Jabil Successfully Closes Mobility Divestiture; Revises Q2 Outlook

By RTTNews Staff Writer   ✉   | Published:   | Follow Us On Google News
rttnewslogo20mar2024

Jabil Inc. (JBL) announced the closing of the transaction to divest its Mobility business to BYD Electronic. With the transaction closing earlier, Jabil now expects the midpoint of the prior guidance range for net revenue and core earnings per share for the second quarter to be lower by approximately $400 million and $0.30, respectively, which aligns with the guidance issued on first quarter earnings call.

For the second quarter, the company now expects core earnings per share in a range of $1.43 - $1.83. Prior guidance range was $1.73 - $2.13. Net revenue is now projected in a range of $6.6 billion - $7.2 billion. Previously, the guidance range was $7.0 billion - $7.6 billion.

CFO Mike Dastoor said: "The earlier close and receipt of funds will enable us to begin initiating plans to reduce stranded costs and executing a series of accelerated buybacks throughout fiscal 2024. As a result, we expect to fully utilize our current $2.5 billion dollar repurchase authorization this fiscal year. These actions give me confidence that we will be able to offset lower income in Q2 and deliver core earnings for fiscal 2024 in excess of $9 per share."

For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com.

For comments and feedback contact: editorial@rttnews.com

Business News

Global Economics Weekly Update: May 11 – May 15, 2026

May 15, 2026 15:25 ET
Apart from the confirmation of Kevin Warsh as the next Fed chair, the main news on the economics front this week included key price data from the U.S. and the first quarter economic growth figures from major economies. Both consumer prices and producer costs have started to reflect the effect of supply shocks due to the Middle East conflict. In Europe, GDP data was in focus, while inflation data from China dominated the news flow in Asia.

Latest Updates on COVID-19